 The primary outcome for the trial is superficial or deep SSI after cesarean according to the CDCs National Healthcare Safety Network definitions. The investigators will also assess other wound complications, adverse events potentially attributable to NPWT and cost-effectiveness as measured by incremental cost per case of SSI prevented and per quality-adjusted life year QALY. 